Global GMP Cytokines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global GMP Cytokines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global GMP Cytokines market size was valued at US$ 143 million in 2024 and is forecast to a readjusted size of USD 246 million by 2031 with a CAGR of 8.2% during review period.

Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.

Drivers:

Increasing demand for cell and gene therapies: The rise of cell-based and gene therapies, such as CAR-T therapies and regenerative medicine, has significantly increased the demand for high-quality, GMP (Good Manufacturing Practice) cytokines. Cytokines play a crucial role in cell expansion and differentiation, making them essential in the manufacturing process of these therapies.

Growth in biopharmaceutical R&D: The pharmaceutical industry's focus on developing innovative biologics, cancer immunotherapies, and personalized medicine has led to a surge in demand for GMP-grade cytokines. These are critical for ensuring the consistency, safety, and effectiveness of drug development and clinical trials.

Advances in stem cell research: The expansion of stem cell research, which requires high-quality cytokines for the differentiation and proliferation of stem cells, has further driven the demand for GMP-grade cytokines in both academic and industrial research settings.

Regulatory requirements: The need for compliance with regulatory standards, especially in clinical trials and drug manufacturing, has heightened the demand for GMP-certified cytokines. These stringent standards ensure that cytokines used in clinical and therapeutic applications are of the highest purity and quality.

Rising interest in cancer immunotherapy: Cytokines are essential components in cancer immunotherapies, which harness the body’s immune system to fight cancer. As immunotherapy research grows, so does the demand for GMP cytokines, particularly in the production of therapies targeting immune modulation.

Challenges:

High production costs: Producing GMP-grade cytokines involves stringent quality controls and highly specialized manufacturing processes, which significantly increase production costs. This makes GMP cytokines expensive, limiting their accessibility, especially for smaller research institutions and companies.

Complexity of manufacturing: The production of GMP cytokines requires sophisticated technologies, including recombinant protein production, purification, and quality control processes, which can be complex and time-consuming. Any deviation in these processes can lead to batch failures, affecting supply chain stability.

Regulatory hurdles: Obtaining regulatory approvals for GMP cytokines used in clinical applications can be a lengthy and challenging process. Manufacturers must meet stringent quality and safety standards, which can delay the availability of new products and limit market growth.

Supply chain issues: The production of GMP cytokines is highly dependent on reliable and consistent raw material supplies. Any disruptions in the supply chain, such as shortages of critical raw materials, can impact production timelines and availability, posing a challenge to manufacturers.

Competition from alternative technologies: As new technologies emerge in the biopharmaceutical industry, such as synthetic biology and non-cytokine-based methods for cell growth and differentiation, the demand for traditional cytokines could be threatened, impacting market growth in the long term.

This report is a detailed and comprehensive analysis for global GMP Cytokines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global GMP Cytokines market size and forecasts, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/µg), 2020-2031

Global GMP Cytokines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/µg), 2020-2031

Global GMP Cytokines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/µg), 2020-2031

Global GMP Cytokines market shares of main players, shipments in revenue ($ Million), sales quantity (mg), and ASP (USD/µg), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for GMP Cytokines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global GMP Cytokines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva, Lonza, ReproCELL, Sino Biological, Akron Biotech, Creative Bioarray, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

GMP Cytokines market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
TNF
Interleukin
Growth Factor
Others

Market segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others

Major players covered
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe GMP Cytokines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of GMP Cytokines, with price, sales quantity, revenue, and global market share of GMP Cytokines from 2020 to 2025.

Chapter 3, the GMP Cytokines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the GMP Cytokines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and GMP Cytokines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of GMP Cytokines.

Chapter 14 and 15, to describe GMP Cytokines sales channel, distributors, customers, research findings and conclusion.